Bio-Works Technologies AB Stock
Equities
BIOWKS
SE0007387089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 SEK | -4.04% | -3.06% | -59.86% |
Sales 2022 | 41.32M 3.82M | Sales 2023 | 43.9M 4.06M | Capitalization | 277M 25.59M |
---|---|---|---|---|---|
Net income 2022 | -45M -4.16M | Net income 2023 | -56M -5.18M | EV / Sales 2022 | 16.2 x |
Net cash position 2022 | 65.88M 6.09M | Net cash position 2023 | 39.38M 3.64M | EV / Sales 2023 | 5.41 x |
P/E ratio 2022 |
-16.4
x | P/E ratio 2023 |
-4.51
x | Employees | 36 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.22% |
1 day | -4.04% | ||
1 week | -3.06% | ||
Current month | -3.06% | ||
1 month | -29.28% | ||
3 months | -47.22% | ||
6 months | -55.33% | ||
Current year | -59.86% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Royce
CEO | Chief Executive Officer | 47 | 20-06-25 |
Founder | - | 05-12-31 | |
Arne Hauge
DFI | Director of Finance/CFO | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 71 | 13-09-23 | |
Johan Sedihn
BRD | Director/Board Member | 59 | 20-05-14 |
Peter Nählstedt
BRD | Director/Board Member | 50 | 20-05-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.85 | -4.04% | 4,158 |
24-05-02 | 2.97 | +1.02% | 4,855 |
24-04-30 | 2.94 | 0.00% | 2,000 |
24-04-29 | 2.94 | 0.00% | 18,303 |
24-04-26 | 2.94 | -2.00% | 46,634 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 10:56 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-59.86% | 10.28M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.66% | 26.59B | |
+3.21% | 26.78B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- BIOWKS Stock